Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer
CTCs serve as feasible biomarkers for predicting postoperative prognosis in NSCLC patients. The combination of hematological, radiological, and pathological features could be valuable tools to guide postoperative management and treatment decisions in these patients. A multimodal prognostic approach is important for the clinical evaluation of lung cancer.
Authors
- Jinghan Song
- Hui Xiao (ORCID: https://orcid.org/0000-0002-1465-4596)
- Xiaogang Ying (ORCID: https://orcid.org/0000-0002-7238-5451)
- Ye Xiong (ORCID: https://orcid.org/0000-0001-9770-6031)
- Qianqian Peng (ORCID: https://orcid.org/0000-0001-7740-3009)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
- Shanghai First People's Hospital (CN)
- Shanghai University of Medicine and Health Sciences (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1186/s12885-024-13245-y
- Citations
- 5
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- National Natural Science Foundation of China